BridgeMD
Tests treatment safety and results for Myofascial Trigger Point Pain
Official title The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.
ClinicalTrials.gov ID: NCT06338514
What this study is testing
- What it's testing
- Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhomboid and trapezius trigger point.
- Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher.
- Ability to read and write
You likely can't join if
- History of spinal surgery.
- Lesions, atrophy, or scars in the skin around the back.
- Undergoing physiotherapy targeting the back and lumbar region in the last 6 months.
- Undergoing an treatment procedure for back or lumbar pain in the last 3 months.
- Use of steroids in the last 1 month.
- Special conditions such as epilepsy, pregnancy, injection phobia, etc.
See the full eligibility criteria
- Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhomboid and trapezius trigger point.
- Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher.
- Ability to read and write
- History of spinal surgery.
- Lesions, atrophy, or scars in the skin around the back.
- Undergoing physiotherapy targeting the back and lumbar region in the last 6 months.
- Undergoing an treatment procedure for back or lumbar pain in the last 3 months.
- Use of steroids in the last 1 month.
- Special conditions such as epilepsy, pregnancy, injection phobia, etc.
- Inability to comply with the restriction on the use of steroid and non-steroidal anti-inflammatory drugs during the treatment period.
The study team makes the final eligibility decision.
Where it's taking place
- Kütahya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kütahya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.